"Rectal Cancer" trang 1 - tải miễn phí từ tailieunhanh
Identification of genes inducing resistance to ionizing radiation in human rectal cancer cell lines: Re-sensitization of radio-resistant rectal cancer cells through down regulating NDRG1

Identification of genes inducing resistance to ionizing radiation in human rectal cancer cell lines: Re-sensitization of radio-resistant rectal cancer cells through down regulating NDRG1
14    70    1
Benchmarking trial between France and Australia comparing management of primary rectal cancer beyond TME and locally recurrent rectal cancer (PelviCare Trial): Rationale and design

Benchmarking trial between France and Australia comparing management of primary rectal cancer beyond TME and locally recurrent rectal cancer (PelviCare Trial): Rationale and design
7    84    1
The role of endoscopic ultrasound in the staging of rectal cancer

The role of endoscopic ultrasound in the staging of rectal cancer
7    95    0
Randomized phase II study comparing the efficacy and safety of SOX versus mFOLFOX6 as neoadjuvant chemotherapy without radiotherapy for locally advanced rectal cancer (KSCC1301)

Randomized phase II study comparing the efficacy and safety of SOX versus mFOLFOX6 as neoadjuvant chemotherapy without radiotherapy for locally advanced rectal cancer (KSCC1301)
9    42    1
Complete pathological response following neoadjuvant FOLFOX chemotherapy in BRCA2-mutant locally advanced rectal cancer: A case report

Complete pathological response following neoadjuvant FOLFOX chemotherapy in BRCA2-mutant locally advanced rectal cancer: A case report
5    53    1
Influence of tumor location on short- and long-term outcomes after laparoscopic surgery for rectal cancer: A propensity score matched cohort study

Influence of tumor location on short- and long-term outcomes after laparoscopic surgery for rectal cancer: A propensity score matched cohort study
12    51    1
Preoperative chemoradiotherapy with capecitabine and triweekly oxaliplatin versus capecitabine monotherapy for locally advanced rectal cancer: A propensity-score matched study

Preoperative chemoradiotherapy with capecitabine and triweekly oxaliplatin versus capecitabine monotherapy for locally advanced rectal cancer: A propensity-score matched study
13    24    1
Machine learning-based multiparametric MRI radiomics for predicting poor responders after neoadjuvant chemoradiotherapy in rectal Cancer patients

Machine learning-based multiparametric MRI radiomics for predicting poor responders after neoadjuvant chemoradiotherapy in rectal Cancer patients
11    21    1
Image-guided navigation for locally advanced primary and locally recurrent rectal cancer: Evaluation of its early cost-effectiveness

Image-guided navigation for locally advanced primary and locally recurrent rectal cancer: Evaluation of its early cost-effectiveness
14    26    1
Preliminary results of robotic approach in rectal cancer surgery

Preliminary results of robotic approach in rectal cancer surgery
8    73    0
Organ Preservation in Rectal Adenocarcinoma: A phase II randomized controlled trial evaluating 3-year disease-free survival in patients with locally advanced rectal cancer treated with chemoradiation plus induction or consolidation chemotherapy, and total mesorectal excision or nonoperative management

Organ Preservation in Rectal Adenocarcinoma: A phase II randomized controlled trial evaluating 3-year disease-free survival in patients with locally advanced rectal cancer treated with chemoradiation plus induction or consolidation chemotherapy, and total mesorectal excision or nonoperative management
13    86    1
Short-course radiation followed by mFOLFOX-6 plus avelumab for locallyadvanced rectal adenocarcinoma

Short-course radiation followed by mFOLFOX-6 plus avelumab for locallyadvanced rectal adenocarcinoma
11    43    1
Transanal total mesorectal excision laparoscopic surgery for rectal cancer treatment: Short-term outcomes in 57 patients

Transanal total mesorectal excision laparoscopic surgery for rectal cancer treatment: Short-term outcomes in 57 patients
8    67    1
Transanal total mesorectal excision in treatment of mid-low rectal cancer: Double-team or single-team?

Transanal total mesorectal excision in treatment of mid-low rectal cancer: Double-team or single-team?
8    47    1
Optimize the dose of oxaliplatin for locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy followed by radical surgery and adjuvant chemotherapy

Optimize the dose of oxaliplatin for locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy followed by radical surgery and adjuvant chemotherapy
10    61    1
Colon and rectal cancer treatment patterns and their associations with clinical, sociodemographic and lifestyle characteristics: Analysis of the Australian 45 and Up Study cohort

Colon and rectal cancer treatment patterns and their associations with clinical, sociodemographic and lifestyle characteristics: Analysis of the Australian 45 and Up Study cohort
13    1    1
Is detection of intraperitoneal exfoliated tumor cells after surgical resection of rectal cancer a prognostic factor of survival

Is detection of intraperitoneal exfoliated tumor cells after surgical resection of rectal cancer a prognostic factor of survival
8    65    1
Circulating proteins in response to combined-modality therapy in rectal cancer identified by antibody array screening

Circulating proteins in response to combined-modality therapy in rectal cancer identified by antibody array screening
11    40    1
Severe myositis of the hip flexors after pre-operative chemoradiation therapy for locally advanced rectal cancer: Case report

Severe myositis of the hip flexors after pre-operative chemoradiation therapy for locally advanced rectal cancer: Case report
6    59    1
Bevacizumab and Combination Chemotherapy in rectal cancer Until Surgery (BACCHUS): A phase II, multicentre, open-label, randomised study of neoadjuvant chemotherapy alone in patients with high-risk cancer of the rectum

Bevacizumab and Combination Chemotherapy in rectal cancer Until Surgery (BACCHUS): A phase II, multicentre, open-label, randomised study of neoadjuvant chemotherapy alone in patients with high-risk cancer of the rectum
10    76    1